Research ExplorerJournalsANN ONCOL Publications

ANN ONCOL

51 - 100 out of 108Page size: 50

Publications

  1. 2013

  2. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Oldenburg, J., Fosså, S. D., Nuver, J., Heidenreich, A., Schmoll, H-J., Bokemeyer, C., Horwich, A., Beyer, J., Kataja, V. & ESMO Guidelines Committee, 01.10.2013, In: ANN ONCOL. 24 Suppl 6, p. vi125-32

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Osteosarcoma of the mobile spine

    Zils, K., Bielack, S., Wilhelm, M., Werner, M., Schwarz, R., Windhager, R., Hofmann-Wackersreuther, G., Andus, T., Kager, L., Kuehne, T., Reichardt, P. & von Kalle, T., 01.08.2013, In: ANN ONCOL. 24, 8, p. 2190-5 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma

    Uzunoglu, F. G., Kolbe, J., Wikman, H., Güngör, C., Bohn, B. A., Nentwich, M. F., Reeh, M., König, A. M., Bockhorn, M., Kutup, A., Mann, O., Izbicki, J. R. & Vashist, Y. K., 01.05.2013, In: ANN ONCOL. 24, 5, p. 1282-90 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Vehreschild, M. J. G. T., Vehreschild, J. J., Hübel, K., Hentrich, M., Schmidt-Hieber, M., Christopeit, M., Maschmeyer, G., Schalk, E., Cornely, O. A., Neumann, S. & German Society of Hematology and Oncology, 05.2013, In: ANN ONCOL. 24, 5, p. 1189-202 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.

    Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N. W., Claßen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K., Flechon, A., Fossa, S. D., Germá Lluch, J. R., Gietema, J. A., Gillessen, S., Giwercman, A., Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C. & Wittekind, C., 2013, In: ANN ONCOL. 24, 4, p. 878-888 11 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use.

    Eiermann, W., Rezai, M., Kümmel, S., Kühn, T., Warm, M., Friedrichs, K., Schneeweiss, A., Markmann, S., Eggemann, H., Hilfrich, J., Jackisch, C., Witzel, I., Eidtmann, H., Bachinger, A., Hell, S. & Blohmer, J., 2013, In: ANN ONCOL. 24, 3, p. 618-624 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2012

  9. Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.

    Le Gouill, S., Kröger, N., Dhedin, N., Nagler, A., Bouabdallah, K., Yakoub-Agha, I., Kanouni, T., Bulabois, C. E., Tournilhac, O., Buzyn, A., Rio, B., Moles, M. P., Shimoni, A., Bacher, U., Ocheni, S., Milpied, N., Harousseau, J. L., Moreau, P., Leux, C. & Mohty, M., 01.10.2012, In: ANN ONCOL. 23, 10, p. 2695-2703 9 p., 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

    Wimberger, P., Gilet, H., Gonschior, A-K., Heiss, M. M., Moehler, M., Oskay-Oezcelik, G., Al-Batran, S-E., Schmalfeldt, B., Schmittel, A., Schulze, E. & Parsons, S. L., 08.2012, In: ANN ONCOL. 23, 8, p. 1979-85 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

    Bondong, S., Kiefel, H., Hielscher, T., Zeimet, A. G., Zeillinger, R., Pils, D., Schuster, E., Castillo-Tong, D. C., Cadron, I., Vergote, I., Braicu, I., Sehouli, J., Mahner, S., Fogel, M. & Altevogt, P., 01.07.2012, In: ANN ONCOL. 23, 7, p. 1795-802 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

    Gladieff, L., Ferrero, A., De Rauglaudre, G., Brown, C., Vasey, P., Reinthaller, A., Pujade-Lauraine, E., Reed, N., Lorusso, D., Siena, S., Helland, H., Elit, L. & Mahner, S., 01.05.2012, In: ANN ONCOL. 23, 5, p. 1185-9 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

    Bachner, M., Loriot, Y., Gross-Goupil, M., Zucali, P. A., Horwich, A., Germa-Lluch, J-R., Kollmannsberger, C., Stoiber, F., Fléchon, A., Oechsle, K., Gillessen, S., Oldenburg, J., Cohn-Cedermark, G., Daugaard, G., Morelli, F., Sella, A., Harland, S., Kerst, M., Gampe, J., Dittrich, C., Fizazi, K. & De Santis, M., 01.2012, In: ANN ONCOL. 23, 1, p. 59-64 6 p., 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?

    Heil, J., Buehler, A., Golatta, M., Rom, J., Schipp, A., Harcos, A., Schneeweiss, A., Rauch, G., Sohn, C. & Junkermann, H., 01.2012, In: ANN ONCOL. 23, 1, p. 98-104 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.

    Bianchi, M., Sun, M., Jeldres, C., Shariat, S. F., Trinh, Q-D., Briganti, A., Tian, Z., Schmitges, J., Graefen, M., Perrotte, P., Menon, M., Montorsi, F. & Karakiewicz, P. I., 2012, In: ANN ONCOL. 23, 4, p. 973-980 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

    Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., Nagtegaal, I. D., Beets-Tan, R. G., Arnold, D., Ciardiello, F., Hoff, P., Kerr, D., Köhne, C. H., Labianca, R., Price, T., Scheithauer, W., Sobrero, A., Tabernero, J., Aderka, D., Barroso, S., Bodoky, G., Douillard, J. Y., El Ghazaly, H., Gallardo, J., Garin, A., Glynne-Jones, R., Jordan, K., Meshcheryakov, A., Papamichail, D., Pfeiffer, P., Souglakos, I., Turhal, S. & Cervantes, A., 2012, In: ANN ONCOL. 23, 10, p. 2479-2516 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2011

  18. Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

    Oechsle, K., Honecker, F., Cheng, T., Mayer, F., Czaykowski, P., Winquist, E., Wood, L., Fenner, M., Glaesener, S., Hartmann, J. T., Chi, K., Bokemeyer, C. & Kollmannsberger, C., 01.12.2011, In: ANN ONCOL. 22, 12, p. 2654-60 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings.

    Beck, J., Procopio, G., Bajetta, E., Keilholz, U., Negrier, S., Szczylik, C., Bokemeyer, C., Bracarda, S., Richel, D. J., Staehler, M., Strauss, U. P., Mersmann, S., Burock, K. & Escudier, B., 01.08.2011, In: ANN ONCOL. 22, 8, p. 1812-1823 12 p., 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer

    Dorn, J., Harbeck, N., Kates, R., Gkazepis, A., Scorilas, A., Soosaipillai, A., Diamandis, E., Kiechle, M., Schmalfeldt, B. & Schmitt, M., 04.2011, In: ANN ONCOL. 22, 4, p. 877-83 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974).

    Daugaard, G., Skoneczna, I., Aass, N., De Wit, R., De Santis, M., Dumez, H., Marreaud, S., Collette, L., Lluch, J. R. G., Bokemeyer, C. & Schmoll, H. J., 2011, In: ANN ONCOL. 22, p. 1054-1061

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.

    Bokemeyer, C., Bondarenko, I., Hartmann, J. T., de Braud, F., Schuch, G., Zubel, A., Celik, I., Schlichting, M. & Koralewski, P., 2011, In: ANN ONCOL. 22, 7, p. 1535-1546 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy.

    Lips, E. H., Mulder, L., Hannemann, J., Laddach, N., Vrancken Peeters, M. T. F. D., van de Vijver, M. J., Wesseling, J., Nederlof, P. M. & Rodenhuis, S., 2011, In: ANN ONCOL. 22, 4, p. 870-876 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Phase I trial of SU14813 in patients with advanced solid malignancies.

    Fiedler, W., Giaccone, G., Lasch, P., van der Horst, I., Brega, N., Courtney, R., Abbattista, A., Shalinsky, D. R., Bokemeyer, C. & Boven, E., 2011, In: ANN ONCOL. 22, 1, p. 195-201 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.

    Untch, M., Fasching, P. A., Konecny, G. E., von Koch, F., Conrad, U., Fett, W., Kurzeder, C., Lück, H-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Schuster, T., Nekljudova, V., Lebeau, A., Loibl, S., von Minckwitz, G. & Investigators, A. G. O. PREPARE., 2011, In: ANN ONCOL. 22, 9, p. 1988-1998 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis.

    Untch, M., von Minckwitz, G., Konecny, G. E., Conrad, U., Fett, W., Kurzeder, C., Lück, H-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Beckmann, M. W., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Nekljudova, V., Lebeau, A., Loibl, S., Fasching, P. A. & Investigators, A. G. O. PREPARE., 2011, In: ANN ONCOL. 22, 9, p. 1999-2006 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. 2010

  28. Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study.

    Sehouli, J., Pietzner, K., Harter, P., Münstedt, K., Mahner, S., Hasenburg, A., Camara, O., Wimberger, P., Boehmer, D., Bühling, K. J., Richter, R., El Khalfaoui, K. & Oskay-Ozcelik, G., 01.11.2010, In: ANN ONCOL. 21, 11, p. 2201-2205 5 p., 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation.

    Mautner, V. F., Nguyen, R., Knecht, R. & Bokemeyer, C., 01.11.2010, In: ANN ONCOL. 21, 11, p. 2294-2295 2 p., 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Recall pneumonitis during systemic treatment with sunitinib

    Seidel, C., Janssen, S., Karstens, J. H., Welte, T., Morgan, M., Ganser, A. & Grünwald, V., 10.2010, In: ANN ONCOL. 21, 10, p. 2119-20 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Characteristics of cancer patients using homeopathy compared with those in conventional care: a cross-sectional study

    Guethlin, C., Walach, H., Naumann, J., Bartsch, H-H. & Rostock, M., 05.2010, In: ANN ONCOL. 21, 5, p. 1094-9 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Patients with advanced non-seminomatous germ-cell tumour: the art of the start.

    Honecker, F. & Bokemeyer, C., 2010, In: ANN ONCOL. 21, 8, p. 1569-1571 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.

    Mesía, R., Rivera, F., Kawecki, A., Rottey, S., Hitt, R., Kienzer, H., Cupissol, D., De Raucourt, D., Benasso, M., Koralewski, P., Delord, J-P., Bokemeyer, C., Curran, D., Gross, A. & Vermorken, J. B., 2010, In: ANN ONCOL. 21, 10, p. 1967-1973 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.

    Psyrri, A., Licitra, L., Lacombe, D., Schuuring, E., Budach, W., Ozsahin, M., Knecht, R., Vermorken, J. B. & Langendijk, J. A., 2010, In: ANN ONCOL. 21, 10, p. 1952-1960 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2009

  36. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.

    Ychou, M., Hohenberger, W., Thezenas, S., Navarro, M., Maurel, J., Bokemeyer, C., Shacham-Shmueli, E., Rivera, F., Kwok-Keung Choi, C. & Santoro, A., 2009, In: ANN ONCOL. 20, 12, p. 1964-1970 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.

    Lorch, A., Neubauer, A., Hackenthal, M., Dieing, A., Hartmann, J. T., Rick, O., Bokemeyer, C. & Beyer, J., 2009, In: ANN ONCOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study.

    Aapro, M., Ludwig, H., Bokemeyer, C., MacDonald, K., Soubeyran, P., Turner, M., Albrecht, T. & Abraham, I., 2009, In: ANN ONCOL. 20, 10, p. 1714-1721 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. 2008

  40. [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial.

    De Wit, M., Brenner, W., Hartmann, M., Kotzerke, J., Hellwig, D., Lehmann, J., Franzius, C., Kliesch, S., Schlemmer, M., Tatsch, K., Heicappell, R., Geworski, L., Amthauer, H., Dohmen, B. M., Schirrmeister, H., Cremerius, U., Bokemeyer, C. & Bares, R., 2008, In: ANN ONCOL. 19, 9, p. 1619-1623 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

    Bokemeyer, C., Oechsle, K., Honecker, F., Mayer, F., Hartmann, J. T., Waller, C. F., Böhlke, I. & Kollmannsberger, C., 2008, In: ANN ONCOL. 19, 3, p. 448-453 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.

    Mahner, S., Schirrmacher, S., Brenner, W., Jenicke, L., Habermann, C., Avril, N. & Dose-Schwarz, J., 2008, In: ANN ONCOL. 19, 7, p. 1249-1254 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.

    Köhne, C-H., De Greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K., Braumann, D., Joosens, E., Müller, L., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H-J., Bleiberg, H., Van Den Brande, J., Debois, M., Bethe, U. & Van Cutsem, E., 2008, In: ANN ONCOL. 19, 5, p. 920-926 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.

    Ryan, G., Martinelli, G., Kuper-Hommel, M., Tsang, R., Pruneri, G., Yuen, K., Roos, D., Lennard, A., Devizzi, L., Crabb, S., Hossfeld, D., Pratt, G., Dell'Olio, M., Choo, S. P., Bociek, R. G., Radford, J., Lade, S., Gianni, A. M., Zucca, E., Cavalli, F. & Seymour, J. F., 2008, In: ANN ONCOL. 19, 2, p. 233-241 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up.

    Zander, A. R., Schmoor, C., Kröger, N., Krüger, W., Möbus, V., Frickhofen, N., Metzner, B., Berdel, W. E., Koenigsmann, M., Thiel, E., Wandt, H., Possinger, K., Kreienberg, R., Schumacher, M. & Jonat, W., 2008, In: ANN ONCOL. 19, 6, p. 1082-1089 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Translating genetic pathways to protein networks for cancer sub-typing.

    Eltze, E., Schmidt, H., Semjonow, A. & Brandt, B., 2008, In: ANN ONCOL. 19, 5, p. 44-47 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Trastuzumab in pregnancy associated with poor fetal outcome.

    Witzel, I., Müller, V., Harps, E., Jänicke, F. & De Wit, M., 2008, In: ANN ONCOL. 19, 1, p. 191-192 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. 2007

  49. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.

    Reichmann, U., Bokemeyer, C., Wallwiener, D., Bamberg, M. & Huober, J., 2007, In: ANN ONCOL. 18, 12, p. 1981-1984 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

    Mouridsen, H. T., Langer, S. W., Buter, J., Eidtmann, H., Rosti, G., De Wit, M., Knoblauch, P., Rasmussen, A., Dahlstrøm, K., Jensen, P. B. & Giaccone, G., 2007, In: ANN ONCOL. 18, 3, p. 546-550 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. 2006

  52. A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)

    Kollmannsberger, C., Schittenhelm, M., Honecker, F., Tillner, J., Weber, D., Oechsle, K., Kanz, L. & Bokemeyer, C., 06.2006, In: ANN ONCOL. 17, 6, p. 1007-13 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer:results of a multicenter phase-II trial

    Sehouli, J., Oskay-Ozcelik, G., Kühne, J., Stengel, D., Hindenburg, H-J., Klare, P., Heinrich, G., Schmalfeldt, B., Mertens, H., Camara, O., Lichtenegger, W. & Ovarian Cancer Study Group of the North-Eastern Germany Society of Gynecological Oncology (NOGGO), 06.2006, In: ANN ONCOL. 17, 6, p. 957-61 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic Tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)

    du Bois, A., Burges, A., Meier, W., Pfisterer, J., Schmalfeldt, B., Richter, B., Jackisch, C., Staehle, A., Kimmig, R., Elser, G. & Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom, 01.2006, In: ANN ONCOL. 17, 1, p. 93-6 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects.

    Scherwath, A., Mehnert, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., Metzner, B., Thiel, E., Zander, A. R., Schulz-Kindermann, F. & Koch, U., 2006, In: ANN ONCOL. 17, 3, p. 415-423 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. 2005

  57. Non-enrolment of ovarian cancer patients in clinical Trials: reasons and background

    Harter, P., du Bois, A., Schade-Brittinger, C., Burges, A., Wollschlaeger, K., Gropp, M., Schmalfeldt, B., Huober, J., Staehle, A. & Pfisterer, J., 11.2005, In: ANN ONCOL. 16, 11, p. 1801-5 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO

    Kollmannsberger, C., Budach, W., Stahl, M., Schleucher, N., Hehr, T., Wilke, H., Schleicher, J., Vanhoefer, U., Jehle, E. C., Oechsle, K., Trarbach, T., Boehlke, I., Kanz, L., Hartmann, J. T. & Bokemeyer, C., 08.2005, In: ANN ONCOL. 16, 8, p. 1326-33 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  59. 2004

  60. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach.

    Keller, M., Sommerfeldt, S., Fischer, C., Knight, L., Riesbeck, M., Löwe, B., Herfarth, C. & Lehnert, T., 2004, In: ANN ONCOL. 15, 8, p. 1243-1249 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next